Page last updated: 2024-08-25

nsc 361456 and Cholera Infantum

nsc 361456 has been researched along with Cholera Infantum in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ames, MM; Dhodapkar, MV; Reid, JM; Richardson, RL1

Trials

1 trial(s) available for nsc 361456 and Cholera Infantum

ArticleYear
Pyrazine diazohydroxide (NSC-361456). Phase I clinical and pharmacokinetic studies.
    Investigational new drugs, 1994, Volume: 12, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Drug Tolerance; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Pyrazines

1994